{"title":"High dimensional profiling of immune responses to kidney transplant reveals heterogeneous T helper 1 and B cell effectors associated with rejection.","authors":"Kevin Louis,Tracy Tabib,Camila Macedo,Jiefei Wang,Paul Cantalupo,Uma Chandran,Xinyan Gu,Michelle Lucas,Parmjeet Randhawa,Marisa Abundis,Jishnu Das,Harinder Singh,Carmen Lefaucheur,Diana Metes","doi":"10.1016/j.ajt.2024.10.009","DOIUrl":null,"url":null,"abstract":"Rejection is a primary cause of allograft dysfunction after kidney transplantation. Diversity of immune subpopulations involved in the different endotypes of rejection remains to be delineated at single-cell resolution. In a cohort of 76 kidney transplant recipients, we conducted high-dimensional immune phenotyping of blood CD4 T and B cells, single-cell RNA and T/B cell receptor sequencing and plasma cytokine profiling. Phenotypic, transcriptional and clonal states of CD4T and B cells could significantly distinguish stable allograft state from rejection. Patients undergoing T-cell mediated rejection displayed accumulation of clonally expanded of cytotoxic T helper (Th)1 cells and of Th17-like cells, associated with predominant naive B cell responses. In contrast, antibody-mediated rejection was characterized by clonal expansion of Th1-polarized T follicular helper (Tfh) cells and effector T-bet+ memory B cells, both of which strongly expressed IL-12 and TNF-signaling pathways. Plasma cytokine analysis confirmed mixed Th1/Th17 and Th1/Tfh-driven inflammatory profiles distinguishing T-cell mediated rejection and antibody-mediated rejection, respectively. CD4T and B cell subpopulations and signatures were validated by bulk RNA-seq analysis of matched kidney allografts and using an independent single-cell RNAseq dataset. These data improve mechanistic understanding of immune pathogenesis of rejection and support development of more specific immunosuppressive therapies to treat allograft rejection.","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"8 1","pages":""},"PeriodicalIF":8.9000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajt.2024.10.009","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Rejection is a primary cause of allograft dysfunction after kidney transplantation. Diversity of immune subpopulations involved in the different endotypes of rejection remains to be delineated at single-cell resolution. In a cohort of 76 kidney transplant recipients, we conducted high-dimensional immune phenotyping of blood CD4 T and B cells, single-cell RNA and T/B cell receptor sequencing and plasma cytokine profiling. Phenotypic, transcriptional and clonal states of CD4T and B cells could significantly distinguish stable allograft state from rejection. Patients undergoing T-cell mediated rejection displayed accumulation of clonally expanded of cytotoxic T helper (Th)1 cells and of Th17-like cells, associated with predominant naive B cell responses. In contrast, antibody-mediated rejection was characterized by clonal expansion of Th1-polarized T follicular helper (Tfh) cells and effector T-bet+ memory B cells, both of which strongly expressed IL-12 and TNF-signaling pathways. Plasma cytokine analysis confirmed mixed Th1/Th17 and Th1/Tfh-driven inflammatory profiles distinguishing T-cell mediated rejection and antibody-mediated rejection, respectively. CD4T and B cell subpopulations and signatures were validated by bulk RNA-seq analysis of matched kidney allografts and using an independent single-cell RNAseq dataset. These data improve mechanistic understanding of immune pathogenesis of rejection and support development of more specific immunosuppressive therapies to treat allograft rejection.
期刊介绍:
The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide.
The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.